Similar analyses were performed on the TB+HIV+ arm of the cohort and comparable results were obtained, where IP-10 and VEGF levels significantly decreased upon TB therapy (p<0.0001 and p = 0.04, respectively; Figure S1). The gene discussed is CXCL10; the disease is tuberculosis.